Long Sui is a Professor of Gynecology at Fudan University. He obtained his M.D. and Ph.D. in Gynecologic Oncology from Fudan University. He was a member at large of the IFCPC (International Federation of Cervical Pathology and Colposcopy) (2017-2023); Currently serving as a member of the IFCPC Continuing Education and Training Expert Committee (2023-); Vice Chairman of the Chinese Society of Colposcopy and Cervical Pathology (CSCCP), and Vice Chairman of the Chinese Association of Obstetricians and Gynecologists, Colposcopy and Cervical Diseases Committee (CCNC).
Dr. Sui currently leads the Medical Center for Cervical Diseases and the Hysteroscopy Center in Obs & Gyn Hospital, Fudan University. He has studied colposcopy and HRA techniques in the UK (Albert Singer), the United States (BIDMC, Boston), and Germany, currently practicing colposcopy for 22 years and HRA for 15 years. His research and clinical practice primarily focus on the prevention and treatment of anal and lower genital tract precancerous lesions, as well as the broader field of HPV infection. Notably, he has taken part in and led three nationwide multicenter clinical studies on the 9-valent HPV vaccine for men, contributing significantly to the advancement of public health strategies against HPV-related cancers.
Throughout his career, Dr. Sui has received numerous accolades, including prestigious research grants and awards, for his contributions to women's health.